Fenne Smits,Kaz Groen,Mark‐David Levin,Claudia A.M. Stege,Roel J.W. van Kampen,Ellen van der Spek,Yavuz M. Bilgin,Noortje Thielen,Inger S. Nijhof,Inge Ludwig,Esther G.M. De Waal,Yorick Sandberg,Alain Kentos,Gert-Jan Timmers,Josien C. Regelink,Matthijs Westerman,Koen de Heer,Marie‐Christiane Vekemans,Nazik Durdu-Rayman,Nicole C.H.P. de Graauw
The level of frailty, according to the IMWG frailty index, is highly dynamic during anti-myeloma treatment. Dynamic frailty assessment improved the prediction of survival and early mortality as compared to the prognostic value of static frailty level at baseline. HOVON 143: NTR6297 HOVON 123: NTR4244